Start with 0.5-1mg daily if injecting, or a 1-2% topical product applied once daily
Australia, Canada, and EU In Australia, AOD9604 is classified as a prescription-only medication by the Therapeutic Goods Administration (TGA) (Poisons Standard Appendix D lists AOD9604
BPC-157 and TB-500 must be kept in separate vials and administered as separate injections
Common effects usually mild and often worst during titration include nausea, vomiting, diarrhea, constipation, abdominal pain, upset stomach, headache, and fatigue
The compound's high membrane permeability and metabolic stability make it suitable for both acute and chronic study designs, but researchers should be aware that its effects on NAD+ and methylation metabolism may require time to fully manifest
Regrowth Serum This guide breaks down the key differences between MDhair's copper peptide and biotinoyl peptide formulas